Amalgamation/ Merger / Demerger
We hereby inform that the Scheme of Amalgamation of M/s. Amrutanjan Pharmaessense Private Limited (Transferor) with M/s. Amrutanjan Health Care Limited (Transferee)was approved by the National Company Law Tribunal (NCLT) , Chennai vide their order dated July 13, 2017. e- form INC-28 has been filed with the Registrar of Companies on July 19, 2017 (SRN no.- G48623755) in pursuant to the above order Shareholding for the Period Ended June 30, 2017
Amrutanjan Health Care Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended June 30, 2017
Statement of Investor Grievance Report for the quarter ended June 30, 2017 Board recommends Final Dividend
Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 16, 2017, inter alia, has recommended Final Dividend of Rs. 1.65 per equity share of Rs. 2 each for the financial year 2016- 2017 in addition to interim dividends of Rs. 2.20 per equity share (2 interim dividends of Rs. 1.10 each per equity share) declared and paid during the financial year 2016-17. The total dividend payout for 2016-17... Financial Results For May 16, 2017
The Board of Amrutanjan Health Care Limited approved the Audited Standalone and Consolidated Financial Results for the Quarter and Year ended March 31st, 2017, as recommended by the audit committee at its meeting held today (May 16, 2017). The same along with the Report issued by M/s. P.S. Subramania Iyer & Co , Chartered Accountants; Statutory Auditors is enclosed; Outcome of Board Meeting
The Company hereby informs that the Board of directors in their meeting held today (May 16, 2017) hereby a.Approved the Audited Standalone and Consolidated Financial Results for the Quarter and Year ended March 31st, 2017, as recommended by the audit committee at its meeting held today (May 16, 2017). The same along with the Report issued by M/s. P.S. Subramania Iyer & Co , Chartered Accountants; Statutory Auditors b.Recommended Final Dividend... Updates
This is to inform that the management of the Company has framed a 'Capital Return Policy' for the benefit of all the shareholders and potential investors. A copy of the same can also be accessed from the website of the Company www.amrutanjan.com Board to consider Final Dividend
Amrutanjan Health Care Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on May 16, 2017, inter alia, to consider and approve the following:1. Audited Standalone and Consolidated Financial Results along with the Report of the Statutory Auditor for the Quarter and Year ended March 31, 2017.2. Declaration of Final Dividend for the financial year 2016-17; if any... Board Meeting On May 16,2017
The Company hereby informs that a meeting of the Board of Directors is scheduled to be held on Tuesday, May 16, 2017 at the registered office of the Company to consider and approve, inter-alia, the following: 1.Audited Standalone and Consolidated Financial Results along with the Report of the Statutory Auditor for the Quarter and Year ended 31st March, 2017. 2.Declaration of Final Dividend for the financial year 2016-17; if any